Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Myval TAVR valve non-inferior to Sapien 3 after 1 year—pacemaker implants the biggest difference
India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients.
AI-powered risk model evaluates long-term risk of coronary artery disease
The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available.
Tracking major trends and clinical research in acute coronary syndrome care
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.
Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves
Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes.
Resilia tissue developed by Edwards Lifesciences linked to long-term benefits
Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt.

Is a COVID showdown ahead between Google–Apple and governments?

Governments around the world have their own COVID contact-tracing apps already up and running—and several U.S. states have indicated they like their own solutions just fine.

Another way work-related stress can impact your cardiovascular health

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

5 notable quotes from COVID-19 physicians

Several physicians on the front lines of the battle against COVID-19 have taken to the pages of online and print publications to share their firsthand experiences.

New research highlights the connection between venous thromboembolism and COVID-19

Hospitalized COVID-19 patients experience a high rate of thromboembolic complications, according to new findings published in Thrombosis Research.

Heart attack care is different for male and female patients—and the inconsistency can lead to fatal results

Women are prescribed fewer drugs after a heart attack than men—and they are more likely to die afterward as a result of that disparity.

How do blood pressure medications affect coronavirus patients? Specialists hope to crack the code

Researchers have launched a new multi-center clinical trial aimed at learning more about how various blood pressure medications impact the health of patients with COVID-19.

Embracing salt substitutes could help China prevent 450K CVD deaths per year

The team also found that such a shift could prevent more than 740,000 non-fatal CVD events annually and decrease new chronic kidney disease cases by nearly 7%.

CAD deaths on the rise among young women in rural areas

Women in rural parts of the United States have experienced an increase in premature coronary artery disease (CAD) mortality, according to new findings published in the Journal of the American Heart Association.

Clinical

Myval TAVR valve non-inferior to Sapien 3 after 1 year—pacemaker implants the biggest difference

AI-powered risk model evaluates long-term risk of coronary artery disease

Tracking major trends and clinical research in acute coronary syndrome care

Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits